She thinks she's pretty much perfect, and having one thing about herself she doesn't like won't convince me that Tuna is a ~dark twisted individual full of self-hate. She clearly doesn't fit that image, and she's trying to make herself appear like that but it's 100% fake. Pic related, it's a call-out post from one of her old friends, seeing as people in here seem too newfag to know Luna's ways.
Your doctor or nurse will look at your skin and measure your weight and blood pressure. They’ll ask questions about your period, any symptoms you may be having, and your personal and family health history. They may do a pelvic exam and blood tests to check your hormone levels, whether you may be pregnant, and more. In some cases, your doctor or nurse may recommend getting an ultrasound to check for ovarian cysts.
I feel like you're confused, which is fair Luna can be all over the place and cryptic. Her father in law type guy had hella health issues last year which was her main excuse for most of her e-begging when it was at its height. From my understanding he has some drinking issues and he and Lurch get in a lot of fights, but he's not a crackhead and it's not nice (I know this isn't a place where people come to be nice) to call sick old men gross.
Clinically speaking, the hyperandrogenism seen in PCOS is associated with hirsutism more than acne or alopecia and therefore hirsutism is an impetus for young women seeking care. Many PCOS women are also overweight (BMI > 25kg/m2) or obese (BMI > 30kg/m2), although adiposity is not a defining criteria for PCOS. Obesity is highly prevalent in the general population and in PCOS women and is an independent risk factor for CAD. Obesity in adolescents is correlated with insulin resistance (IR) and dyslipidemia. PCOS related ovulatory dysfunction in adolescents often correlates to adolescent obesity. Genetic predisposition to PCOS has been suspected for many years and data link obesity and metabolic disturbances in PCOS with genetic polymorphisms[7,8]. Even male first degree relatives of women with PCOS have a higher incidence of metabolic syndrome (MS), the closest corollary to PCOS in men.
There is growing evidence that mood disturbances, mostly severe depression, are common in PCOS women , in whom impaired quality of life from body image concerns cause fatigue, sleep disturbance and changes in eating habits. In addition, many PCOS patients report feeling abnormal, unfeminine, and embarrassed due to unwanted hair, often hiding their hair growth and covering their face when talking to others. Understanding how a woman feels about her body image and improving this perception are essential components of any management plan that provides overall health care to women with PCOS.
On June 8, 2011, the FDA notified health care professionals of its recommendations for limiting the use of the highest approved dose (80 mg) of the cholesterol-lowering medication simvastatin (Zocor) because of increased risk of muscle damage. The FDA required changes to the simvastatin label to add new contraindications (should not be used with certain medications) and dose limitations for using simvastatin with certain medications. 
From what I know, all women with PCOS don't have regular period at all! Those who were even trying to conceive needed to a tool to track their ovulation, most of my friends use a free bbt from cocneiveeasy. I have a friend who's trying for months now, unfortunately she has PCOS and still not pregnant, she's taking conceiveeasy along with Clomid now, I hope it works for her.
The risk of developing prediabetes and type 2 diabetes is increased in women with PCOS, particularly if they have a family history of diabetes. Obesity and insulin resistance, both associated with PCOS, are significant risk factor for the development of type 2 diabetes. Several studies have shown that women with PCOS have abnormal levels of LDL ("bad") cholesterol and lowered levels of HDL ("good") cholesterol in the blood. Elevated levels of blood triglycerides have also been described in women with PCOS.
6. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society. The androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456–88. http://dx.doi.org/10.1016/j.fertnstert.2008.06.035 [PubMed]
Gud pm po ask q lng po nung nanganak po kc aq nbinat aq sumakit po ang kaliwang tagiliran q nung ngpachekup po aq ang sv my ovarian cyst dw po aq peru wla aman po aq ibng naramdaman kundi mskt pag malamig lng at pag mlapit na mens q pumipitik po ‘ang sv ng ob .dudurugen lng dw po peru wla naman xa nreseta skn .mula po nun lage nq nakukunan bago 2muntong ng 2 muntz . Anu po kya ang pwd q gawen at inumen .pag mlameg po msaket sv aman po ng ibng doktor ugat lng dw po na namaga s bndang ovary need dw po ilaser …anu po maipapayo nyo tnx
Our search identified 33 laboratory (pre-clinical) studies (Figure 1). Eighteen studies met the inclusion criteria, nine reported on receptor binding assays or ovarian or pituitary (brain) cell cultures, [36–44] and nine used an animal experimental model with hormone assays and/or post-mortem examination of ovarian, uterine and brain histology, [45–53] (Table 1). We excluded 15 studies for the following reasons; investigation of effects in male animals (n = 4) and investigations which commenced with constituents that were isolated from herbal medicines (n = 5). Six studies were excluded due to no clinical evidence found (n = 6).
Polycystic ovary syndrome and fertility: What you need to know PCOS is a disorder in which small fluid-filled cysts form in the ovaries. This leads to an imbalance in female sex hormones, with symptoms such as male-pattern hair growth and irregular periods. It can also affect fertility. Tips and treatment for fertility problems include diet, stress reduction, and medical help. Read now
In contrast, another recent meta-analysis reviewed 26 studies that evaluated the use of letrozole in women with PCOS. The use of letrozole in cycles for timed intercourse was associated with higher live birth (nine studies; OR 1.63; 95% CI: 1.31 to 2.03; n=1783; I2=3%) and clinical pregnancy rates (fourteen studies; OR 1.32; 95% CI: 1.09 to 1.60; n=2066; I2=25%) compared with CC treatment; however, this evidence was poor. Studies comparing the use of letrozole versus ovarian drilling revealed no differences in live birth, clinical pregnancy or OHSS rates. The administration of letrozole for 5 or 10 days at a dose of 5 or 7.5 mg/day displayed similar clinical pregnancy rates 42. A recent study found that the use of letrozole was associated with higher live birth rates and ovulation among 750 infertile women with polycystic ovary syndrome compared with clomiphene 43.
*DISCLAIMER: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. The views and nutritional advice expressed by Luna Smooth are not intended to be a substitute for conventional medical service. If you have a severe medical condition, see your physician of choice. Individual results may vary.
In addition to improving reproductive and metabolic factors, the reduction in body weight may be associated with reduced incidence of complications during pregnancy and the neonatal period. In this context, lifestyle change should be the first choice for weight loss because medications to reduce weight could have side effects and bariatric surgery may be associated with preterm and small for gestational age births 14.
Three RCTs corroborate the positive fertility effects for Cimicifuga racemosa in women with PCOS, used in conjunction and when compared with the pharmaceutical Clomiphene citrate (clomiphene), [65, 68, 71] (Table 2). Results were reported for 441 women and show improved pregnancy rates when Cimicifuga racemosa was added to clomiphene during one menstrual cycle. In a study including women with PCOS (n = 147), pregnancy rates for the group receiving combined therapy (clomiphene 150 mg plus Cimicifuga racemosa 20 mg per day (Klimadynon®)) were 43.3% compared to 20.3% for women receiving only clomiphene  (Table 2). In another study using similar methodology (n = 100) pregnancy rates were 34.8% for the group treated with Cimicifuga racemosa plus clomiphene compared to 17.2% for women treated with clomiphene alone  (Table 2). Another study included women with PCOS and infertility (n = 100) compared Cimicifuga racemosa (Klimadynon®) and clomiphene over three months for hormone concentrations and pregnancy rates. Pregnancy rates were higher in the women in taking Cimicifuga racemosa compared to clomiphene, 14% and 8% respectively; however differences were not statistically significant. This study found significant effects for lowered luteinising hormone for women with PCOS receiving Cimicifuga racemosa compared to clomiphene (p = 0.007) . Findings from clinical studies concur with laboratory and animal studies; however potential risks for bias include performance and collection bias due to lack of blinding (Table 2).
i wonder if luna's dad knows about how much she complains about him. all he would have to do is google her name to see how much she hates him. if i were her dad and i saw the shit she says about me, i'd kick her to the curb. poor dude is letting her have what she wants, when she wants it, and she STILL talks about him like he's a monster. maybe he's a piece of shit but damn, at least he's trying. what an ungrateful brat
Limitations of direct insulin testing and cumbersome calculations have led to research for indirect serum markers to provide evidence of IR. SHBG correlations to IR as previously mentioned have been inconsistent. Adiponectin is a protein found in adipose tissue associated with both inflammation and insulin action. Recent studies have linked plasma adiponectin level to IR (but not hyperandrogenism) measured by HOMA[56-58]. Serum soluble glycoprotein-130 levels (local cytokine) have been inversely correlated to IR. Resistin plasma levels have been correlated with fasting glucose and HOMA-IR in PCOS women. Inhibin A levels in PCOS women were not found to correlate with IR in PCOS women. Most of these serum markers share common limitations and have been poorly studied. How they might vary with different PCOS phenotypes is unknown. None are adequately compared to IR measured by clamp studies. Their usefulness serially in clinical practice to monitor patients over time and undergoing treatment is also unknown. Some genetic work has recently shown promise. Although far from clinical use, microarray analysis of genes in muscle, adipose tissue and the liver shows alterations in the setting of IR. Serum genetic markers may lead to future genetic techniques to detect and monitor IR.
Clomiphene (Clomid) is an oral medication that is the most common treatment used to induce ovulation. The use of both metformin and clomiphene has about the same fertility results as clomiphene use alone. A benefit is that metformin may help reduce the risk for ovarian hyperstimulation syndrome (see also "What is ovarian hyperstimulation syndrome (OHSS) during assisted reproductive technology (ART) fertility treatments. Other treatments to stimulate ovulation include another oral medication called letrozole (Femara) and gonadotropins which are hormones that are given by injection. In vitro fertilization (IVF) and in vitro maturation (IVM) may be other fertility treatment options.
PCOS is a heterogeneous disorder of uncertain cause. There is some evidence that it is a genetic disease. Such evidence includes the familial clustering of cases, greater concordance in monozygotic compared with dizygotic twins and heritability of endocrine and metabolic features of PCOS. There is some evidence that exposure to higher than typical levels of androgens in utero increases the risk of developing PCOS in later life.